Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleSPECIAL CONTRIBUTION

Advances in Pharmacologic Stress Agents: Focus on Regadenoson

Sara G. Johnson and Scott Peters
Journal of Nuclear Medicine Technology September 2010, 38 (3) 163-171; DOI: https://doi.org/10.2967/jnmt.109.065581
Sara G. Johnson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Peters
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 38 no. 3 163-171
DOI 
https://doi.org/10.2967/jnmt.109.065581
PubMed 
20724531

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication July 10, 2009
  • Accepted for publication May 10, 2010
  • Published online August 31, 2010.

Article Versions

  • previous version (August 19, 2010 - 09:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2010 by Society of Nuclear Medicine

Author Information

  1. Sara G. Johnson1 and
  2. Scott Peters2
  1. 1Nuclear Medicine Service, VA San Diego Healthcare System, San Diego, California
  2. 2Astellas Pharma US, Inc., Critical Care/Hospital Products (Cardiovascular), Deerfield, Illinois
  1. For correspondence or reprints contact: Sara G. Johnson, CNMT, NCT, VA San Diego Healthcare System, Nuclear Medicine Service 115, 3350 La Jolla Village Rd., San Diego, CA 92161. E-mail: saragjohnson{at}hotmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 38 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
    Sujethra Vasu, W Patricia Bandettini, Li-Yueh Hsu, Peter Kellman, Steve Leung, Christine Mancini, Sujata M Shanbhag, Joel Wilson, Oscar Julian Booker, Andrew E Arai
    Journal of Cardiovascular Magnetic Resonance 2013 15 1
  • Inducible endothelial leakiness in nanotherapeutic applications
    Nengyi Ni, Weiyi Wang, Yu Sun, Xiao Sun, David Tai Leong
    Biomaterials 2022 287
  • Stress-only SPECT myocardial perfusion imaging: A review
    B.M. Pampana Gowd, Gary V. Heller, Matthew. W. Parker
    Journal of Nuclear Cardiology 2014 21 6
  • A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease
    Karthik Ananthasubramaniam, Robert Weiss, Bruce McNutt, Barbara Klauke, Kathleen Feaheny, Stan Bukofzer
    Journal of Nuclear Cardiology 2012 19 2
  • Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification
    S.S. Koenders, J.D. van Dijk, P.L. Jager, J.P. Ottervanger, C.H. Slump, J.A. van Dalen
    Journal of Nuclear Cardiology 2019 26 3
  • Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives
    Omar H.A. Al-Attraqchi, Mahesh Attimarad, Katharigatta N. Venugopala, Anroop Nair, Noor H.A. Al-Attraqchi
    Current Pharmaceutical Design 2019 25 25
  • CD39 Modulates Hematopoietic Stem Cell Recruitment and Promotes Liver Regeneration in Mice and Humans After Partial Hepatectomy
    Moritz Schmelzle, Constanze Duhme, Wolfgang Junger, Steven D. Salhanick, Yu Chen, Yan Wu, Vasilis Toxavidis, Eva Csizmadia, Lihui Han, Shu Bian, Günter Fürst, Martina Nowak, Seth J. Karp, Wolfram T. Knoefel, Jan Schulte Esch, Simon C. Robson
    Annals of Surgery 2013 257 4
  • Acute Myocardial Infarction During Regadenoson Myocardial Perfusion Imaging
    Sachil Shah, David Parra, Robert S. Rosenstein
    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2013 33 6
  • Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
    R. van Dijk, D. Kuijpers, T. A. M. Kaandorp, P. R. M. van Dijkman, R. Vliegenthart, P. van der Harst, M. Oudkerk
    The International Journal of Cardiovascular Imaging 2017 33 11
  • Measurement Science in the Circulatory System
    Casey M. Jones, Sandra M. Baker-Groberg, Flor A. Cianchetti, Jeremy J. Glynn, Laura D. Healy, Wai Yan Lam, Jonathan W. Nelson, Diana C. Parrish, Kevin G. Phillips, Devon E. Scott-Drechsel, Ian J. Tagge, Jaime E. Zelaya, Monica T. Hinds, Owen J. T. McCarty
    Cellular and Molecular Bioengineering 2014 7 1

Article usage

Article usage: August 2010 to April 2025

AbstractFullPdf
Aug 201033011
Sep 20101602636
Oct 2010126824
Nov 20101041422
Dec 201046211
Jan 201152910
Feb 201136813
Mar 20113333
Apr 2011511211
May 20113046
Jun 2011101910
Jul 20117555
Aug 20119026
Sep 2011933629
Oct 2011656551
Nov 2011864940
Dec 2011495438
Jan 2012707160
Feb 2012797961
Mar 2012886654
Apr 2012695638
May 2012945455
Jun 2012394837
Jul 2012756954
Aug 2012538851
Sep 20121587748
Oct 2012947567
Nov 201210015358
Dec 20124811145
Jan 20138912443
Feb 20136014142
Mar 20135712161
Apr 20137511661
May 20137911056
Jun 2013506719
Jul 2013435828
Aug 2013433629
Sep 2013644630
Oct 2013485033
Nov 2013355029
Dec 2013286124
Jan 2014254916
Feb 2014284121
Mar 2014246733
Apr 2014323623
May 2014153516
Jun 2014344823
Jul 2014238246
Aug 2014508534
Sep 2014428121
Oct 2014757931
Nov 2014506133
Dec 201484319
Jan 2015215828
Feb 2015304022
Mar 2015355334
Apr 2015453922
May 2015284622
Jun 2015395620
Jul 2015204915
Aug 2015194114
Sep 2015673523
Oct 2015305425
Nov 2015204217
Dec 2015224819
Jan 2016267720
Feb 2016296115
Mar 2016568837
Apr 2016455934
May 2016255337
Jun 2016317333
Jul 2016365939
Aug 2016355132
Sep 2016215131
Oct 2016435526
Nov 2016335827
Dec 201612916119
Jan 2017329319
Feb 20171017031
Mar 2017356938
Apr 2017293836
May 2017448149
Jun 2017336135
Jul 2017236329
Aug 2017327534
Sep 2017344336
Oct 2017247339
Nov 2017199237
Dec 201776121
Jan 2018186824
Feb 2018166125
Mar 20181510429
Apr 2018109319
May 2018149617
Jun 20182411531
Jul 20182013320
Aug 20181610618
Sep 2018219610
Oct 2018149915
Nov 20182211324
Dec 20181210421
Jan 2019309222
Feb 20192710819
Mar 2019219017
Apr 2019358533
May 2019236928
Jun 2019175220
Jul 2019185419
Aug 2019207529
Sep 2019134322
Oct 2019224330
Nov 2019133134
Dec 2019102413
Jan 2020293115
Feb 2020141820
Mar 2020152614
Apr 2020111516
May 202092215
Jun 2020111913
Jul 2020132112
Aug 202061114
Sep 202061515
Oct 2020291830
Nov 2020131520
Dec 202024187
Jan 202172423
Feb 202141621
Mar 202171419
Apr 2021103326
May 202161617
Jun 2021113524
Jul 202193816
Aug 202151816
Sep 2021102914
Oct 202123423
Nov 202155218
Dec 202158113
Jan 202247415
Feb 202257915
Mar 202234214
Apr 20225507
May 202273818
Jun 2022164624
Jul 20224327
Aug 2022123810
Sep 202203518
Oct 202254613
Nov 20224458
Dec 20225304
Jan 2023125113
Feb 202374418
Mar 202313211
Apr 20234269
May 202312229
Jun 202352611
Jul 202362616
Aug 20234217
Sep 202372615
Oct 20231112510
Nov 20231329916
Dec 20231812614
Jan 202445364
Feb 2024165312
Mar 202454726
Apr 202454125
May 2024106531
Jun 2024205920
Jul 202454620
Aug 2024206525
Sep 2024107934
Oct 2024194217
Nov 2024146412
Dec 202485011
Jan 202534418
Feb 202569411
Mar 20251311719
Apr 2025198340
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 38 (3)
Journal of Nuclear Medicine Technology
Vol. 38, Issue 3
September 1, 2010
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Advances in Pharmacologic Stress Agents: Focus on Regadenoson
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Advances in Pharmacologic Stress Agents: Focus on Regadenoson
Sara G. Johnson, Scott Peters
Journal of Nuclear Medicine Technology Sep 2010, 38 (3) 163-171; DOI: 10.2967/jnmt.109.065581

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Advances in Pharmacologic Stress Agents: Focus on Regadenoson
Sara G. Johnson, Scott Peters
Journal of Nuclear Medicine Technology Sep 2010, 38 (3) 163-171; DOI: 10.2967/jnmt.109.065581
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • PHARMACOLOGIC STRESS AGENTS
    • A2A RECEPTOR AGONISTS
    • REGADENOSON
    • PRACTICAL ASPECTS
    • CONCLUSION
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Nuclear Medicine Clinical Practice in the United States During the COVID-19 Era and Beyond
  • Google Scholar

More in this TOC Section

  • Gender and Ethnicity Bias of Text-to-Image Generative Artificial Intelligence in Medical Imaging, Part 1: Preliminary Evaluation
  • Gender and Ethnicity Bias of Text-to-Image Generative Artificial Intelligence in Medical Imaging, Part 2: Analysis of DALL-E 3
  • The Impact of the Coronavirus Disease 2019 Pandemic on the Clinical Environment
Show more Special Contribution

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire